Abington, United Kingdom

Xavier Barril-Alonso



Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • Cambridge, GB (2007)
  • Granta Park, Abington, Cambridge CB1 6GB, GB (2010)
  • Abington, GB (2014)

Company Filing History:


Years Active: 2007-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Xavier Barril-Alonso

Introduction

Xavier Barril-Alonso is a notable inventor based in Abington, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target cancer treatment. With a total of three patents to his name, Barril-Alonso's work is recognized for its potential impact on healthcare.

Latest Patents

One of his latest patents involves substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors. These compounds are designed to inhibit HSP90 activity both in vitro and in vivo, making them useful in the treatment of various cancers. The patent details a specific formula where Ris a group of formula —(Ar)-(Alk)-(Z)-(Alk2)-Q, with Ar representing an optionally substituted aryl or heteroaryl radical. The complexity of the chemical structures involved highlights the innovative nature of his work.

Career Highlights

Throughout his career, Barril-Alonso has worked with prominent organizations such as Cancer Research Technology Limited and Vernalis (Cambridge) Limited. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Martin James Drysdale and Brian William Dymock. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.

Conclusion

Xavier Barril-Alonso's contributions to medicinal chemistry and his innovative patents position him as a key figure in the fight against cancer. His work continues to inspire advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…